Introduction and objective:
Guillain-Barré syndrome (GBS) is a complex clinical entity with an autoimmune basis. It is considered the most common cause of acute neuromuscular paralysis in children. The incidence of GBS is approximately 0.34 per 100 000 cases annually, with a higher prevalence in the male population. The cause of the incidence is considered to be a complication of infection or vaccination.

Review methods:
The studies cited in the presented review were selected from PUBMED. The key words used for the search included: ‘Guillain-Barré syndrom’, ‘Guillain-Barré treatment’, and ‘Guillain-Barré therapeutic methods’. Articles not written in English, conference abstracts only and duplicated papers were excluded.

Brief description of the state of knowledge:
In the 19th century, abnormalities in albimuno-cytological dissection were considered to be the cause, but today diagnostic criteria have evolved. The most important element in the diagnosis of patients is the analysis of cerebrospinal fluid and nerve conduction studies. Possible pathogens that may cause symptoms of the disease include viruses such as Epstein-Barr virus, varicella, cytomegalovirus, and SARS-CoV-2. GBS manifests itself with numerous neurological and cardiovascular symptoms, including bilateral limb weakness, facial paralysis or cardiac arrhythmias. Patient treatment includes immunotherapy immediately after diagnosis.

GBS is a rapidly progressive and difficult to treat clinical entity. It is important to make a timely diagnosis and immediately implement therapy to reduce the risk of death. Further clinical research is needed to find new therapeutic options for young patients.

Bazaraa H, Rady H, Mohamed S, et al. Initial Response and Outcome of Critically Ill Children With Guillain Barre’ Syndrome. Front Pediatr. 2019 Sep; 18(7).
Fadila, Kumar P, Omair MF. Mimics and Chameleons in Guillain-Barré Syndrome. Cureus. 2021 Sep 27;13(9):e18325.
Lupu VV, Miron I, Cianga AL, et al. Diagnostic Pitfalls in Guillain–Barré Syndrome: Case Report and Literature Review. Children. 2022;9(12).
Mamishi S, Reza ASHRAFI M, Mohammadi M, et al. Cytomegalovirus Infection and Guillain-Barré Syndrome: The First Case-Control Study in Iran. Iran J Child Neurol Autumn. 2021;15(4):35–41.
Arnaud S, Budowski C, Ng Wing Tin S, et al. Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020 Jul 1;131(7):1652–4.
Leonhard SE, Mandarakas MR, A Gondim FA, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15, 671–683.
Hu K, Liu W, Gan Y, et al. Transcriptome analysis of childhood Guillain–Barré syndrome associated with supportive care. Front Pediatr. 2022 Sep 26;10.
Alanazy MH, Bakry SS, Alqahtani A, et al. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.BMC Neurol. 2021;21(275)
Asiri S, Altwaijri WA, Ba-Armah D, et al. Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study. Neuropsychiatr Dis Treat. 2019;15:627–635.
Jin M, Zhao L, Liu J, et al. Association Between the Rate of Treatment Response and Short-Term Outcomes in Childhood Guillain-Barré Syndrome. Front Neurol. 2021 Nov 5;12:746389.
Levison LS, Thomsen RW, Markvardsen LK, et al. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020 Jun;107:57–63.
Lupu VV, Miron I, Cianga AL, et al. Diagnostic Pitfalls in Guillain-Barré Syndrome: Case Report and Literature Review. Children (Basel). 2022 Dec 15;9(12):1969.
McCombe PA, Hardy TA, Nona RJ, et al. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. Front Immunol. 2022 Dec 9;13:1038411.
Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020 Mar;25:5–16.
Qinrong H, Yuxia C, Ling L, et al. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children. Dev Med Child Neurol. 2023 Apr;65(4):563–570.
Luo HY, Li XJ, Cheng M, et al. Clinical characteristics of children with Guillain-Barré syndrome and factors associated with disease severity. J Clin Neurosci. 2021 Oct;92:120–125.
Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol. 2015 Apr;15(2):90–9.
Pradhan RR, Yadav SK, Yadav SK Sr. Pharyngeal-Cervical-Brachial variant of Guillian-Barre Syndrome in Children. Cureus. 2020 Feb 13;12(2):e6983.
Tan CY, Razali SNO, Goh KJ, et al. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst. 2019 Jun;24(2):168–173.
Helfferich J, Roodbol J, de Wit MC, et al. 2016 Enterovirus D68 Acute Flaccid Myelitis Working Group and the Dutch Pediatric GBS Study Group. Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria. Eur J Neurol. 2022 Feb;29(2):593–604. https://doi/org/10.1111/ene.15....
Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019 Nov;15(11):671–683.
Zhu J, Zhang Y, Li R, et al. Anti-ganglioside Antibodies in Guillain-Barre Syndrome: A Novel Immunoblotting-Panel Assay. Front Neurol. 2021 Nov 25;12:760889.
Roodbol J, de Wit MY, van den Berg B, et al. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria. J Neurol. 2017 May;264(5):856–861.
Chiu ATG, Chan RWK, Yau MLY, et al. Guillain-Barré syndrome in children – High occurrence of Miller Fisher syndrome in East Asian region. Brain Dev. 2022 Nov;44(10):715–724.
Zaidman CM, Harms MB, Pestronk A. Ultrasound of inherited vs. acquired demyelinating polyneuropathies. J Neurol. 2013 Dec;260(12):3115–21.
Goedee HS, Brekelmans GJ, van Asseldonk JT, et al. High resolution sonography in the evaluation of the peripheral nervous system in polyneuropathy--a review of the literature. Eur J Neurol. 2013 Oct;20(10):1342–51.
Smith N, Pereira J, Grattan-Smith P. Investigation of suspected Guillain-Barre syndrome in childhood: what is the role for gadolinium enhanced magnetic resonance imaging of the spine? J Paediatr Child Health. 2014 Oct;50(10):E72–6.
Rajabally YA. Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics. 01 Apr 2022;19(3):885–896.
Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. 2014; 9 (CD002063).
Shuang L, Chaoling D, Eroboghene E. Immunotherapy of Guillain-Barré syndrome. Human Vaccines & Immunotherapeutics. 2018;14(11):2568–2579.
McGrogan A, Madle GC, Seaman HE, et al. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.
Sejvar JJ, Baughman AL, Wise M, et al. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
Dias-Tosta E, Kückelhaus CS. Guillain Barré syndrome in a population less than 15 years old in Brazil. Arq Neuropsiquiatr. 2002 Jun;60(2-B):367–73.
Delannoy A, Rudant J, Chaignot C, et al. Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008–2013). J Peripher Nerv Syst. 2017 Mar;22(1):51–58.
Chiu ATG, Chan RWK, Yau MLY, et al. Guillain-Barré syndrome in children – High occurrence of Miller Fisher syndrome in East Asian region. Brain Dev. 2022 Nov 1;44(10):715–24.
Tonekaboni SH, Mahmoudi S, Abdollah Gorji F, et al. Epidemiology of Guillain-Barré Syndrome in Iranian Children Aged 0–15 Years (2008–2013). Iran J Child Neurol. 2021 Fall;15(4):27–34.
Zheng P, Tian DC, Xiu Y, et al. Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study. Lancet Reg Health West Pac. 2021 Nov 2;18:100302.
Karalok ZS, Taskin BD, Yanginlar ZB, et al. Guillain-Barré syndrome in children: subtypes and outcome. Childs Nerv Syst. 2018;34:2291–2297.
Nagasawa K, Kuwabara S, Misawa S, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan. Muscle Nerve. 2006;33:766–770.
Gupta PK, Singhi P, Singhi S, et al. How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India. Indian J Pediatr. 2019;86:329–334.
Sen S, Kumar A, Roy B. Clinical Outcome of Guillain-Barré Syndrome in 108 Children. Indian Pediatr. 2021 Sep 15;58(9):833–835.
Ioan A, Iulia L, Lucia S, et al. To be, or not to be. Guillain-Barré Syndrome. Autoimmunity Reviews. 2021;20(12):102983.
Levison L, Thomsen R, Markvardsen L, et al. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatric Neurology. 2020;107:57–63,
Whelan AJ, Tolaymat A, Rainey SC. Bumbling, Stumbling, Fumbling: Weakness, Steppage Gait, and Facial Droop in a 3-Year-Old Male. Glob Pediatr Health. 2019 Jul 24;6:2333794X19865858.
Qinrong H, Yuxia C, Ling L, et al. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children. Dev Med Child Neurol. 2023 Apr;65(4):563–570.
Journals System - logo
Scroll to top